QUEST DIAGNOSTICS INCORPORATED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 144.3 USD | +1.34% |
|
+4.28% | +4.69% |
| 05-16 | Everlasting momentum |  |
| 05-16 | Argus Research Adjusts Quest Diagnostics Price Target to $215 From $163 | MT |
Presenter SpeechHunter Muller (Attendees)Let's move along. Great. So look, thanks for zooming ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
144.3
USD
Average target price
146.8
USD
Spread / Average Target
+1.70%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +4.69% | 15.82B | |
| +19.28% | 84.52B | |
| -26.95% | 72.21B | |
| +4.65% | 27.74B | |
| -7.35% | 17.97B | |
| -0.46% | 17.46B | |
| +8.14% | 13.55B | |
| +6.59% | 13.31B | |
| +70.00% | 12.5B | |
| -1.22% | 12.42B |
- Stock Market
- Equities
- DGX Stock
- News Quest Diagnostics Incorporated
- Transcript : Quest Diagnostics Incorporated Presents at HMG Live! 2020 New Jersey CIO Virtual Summit, Jul-16-2020 01
